This article seeks to review newer ART agents, as well as those in later stages of drug development, for the treatment of HIV-1 infection.
Jeremy D. Young, MD, MPH
Advertisement
Articles by Jeremy D. Young, MD, MPH
Advertisement
Latest Updated Articles
New and Pipeline Antiretroviral Agents for the Treatment of HIV-1 InfectionPublished: June 10th 2016 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
HIV Drug Resistance Declines in the Modern ART Era
2
World AIDS Day 2025: Global Setbacks and New Strategies to Sustain Progress Toward 2030 HIV Targets
3
Ethiopia Investigates Marburg Virus Disease Outbreak
4
Scynexis Collaborates With Hackensack Meridian CDI, Johns Hopkins to Develop Therapeutics for Drug-Resistant Fungal Infections
5
